Cargando…

R WE ready for reimbursement? A round up of developments in real-world evidence relating to health technology assessment: part 10

In this latest update we discuss the transportability of comparative effectiveness evidence across countries. We highlight results of a survey indicating that European HTA agencies are reluctant to accept real-world data from other countries, review recent benefit assessments indicating a potential...

Descripción completa

Detalles Bibliográficos
Autores principales: Simpson, Alex, Ramagopalan, Sreeram V
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Becaris Publishing Ltd 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10288948/
https://www.ncbi.nlm.nih.gov/pubmed/36453665
http://dx.doi.org/10.2217/cer-2022-0194
_version_ 1785062179364405248
author Simpson, Alex
Ramagopalan, Sreeram V
author_facet Simpson, Alex
Ramagopalan, Sreeram V
author_sort Simpson, Alex
collection PubMed
description In this latest update we discuss the transportability of comparative effectiveness evidence across countries. We highlight results of a survey indicating that European HTA agencies are reluctant to accept real-world data from other countries, review recent benefit assessments indicating a potential softening of a requirement for the use of local real-world data in Germany, and outline a recent review presenting approaches that can correct for a lack of transportability.
format Online
Article
Text
id pubmed-10288948
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Becaris Publishing Ltd
record_format MEDLINE/PubMed
spelling pubmed-102889482023-08-11 R WE ready for reimbursement? A round up of developments in real-world evidence relating to health technology assessment: part 10 Simpson, Alex Ramagopalan, Sreeram V J Comp Eff Res Industry Update In this latest update we discuss the transportability of comparative effectiveness evidence across countries. We highlight results of a survey indicating that European HTA agencies are reluctant to accept real-world data from other countries, review recent benefit assessments indicating a potential softening of a requirement for the use of local real-world data in Germany, and outline a recent review presenting approaches that can correct for a lack of transportability. Becaris Publishing Ltd 2022-12-01 /pmc/articles/PMC10288948/ /pubmed/36453665 http://dx.doi.org/10.2217/cer-2022-0194 Text en © 2022 The authors https://creativecommons.org/licenses/by-nc-nd/4.0/This work is licensed under the Attribution-NonCommercial-NoDerivatives 4.0 Unported License (https://creativecommons.org/licenses/by-nc-nd/4.0/)
spellingShingle Industry Update
Simpson, Alex
Ramagopalan, Sreeram V
R WE ready for reimbursement? A round up of developments in real-world evidence relating to health technology assessment: part 10
title R WE ready for reimbursement? A round up of developments in real-world evidence relating to health technology assessment: part 10
title_full R WE ready for reimbursement? A round up of developments in real-world evidence relating to health technology assessment: part 10
title_fullStr R WE ready for reimbursement? A round up of developments in real-world evidence relating to health technology assessment: part 10
title_full_unstemmed R WE ready for reimbursement? A round up of developments in real-world evidence relating to health technology assessment: part 10
title_short R WE ready for reimbursement? A round up of developments in real-world evidence relating to health technology assessment: part 10
title_sort r we ready for reimbursement? a round up of developments in real-world evidence relating to health technology assessment: part 10
topic Industry Update
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10288948/
https://www.ncbi.nlm.nih.gov/pubmed/36453665
http://dx.doi.org/10.2217/cer-2022-0194
work_keys_str_mv AT simpsonalex rwereadyforreimbursementaroundupofdevelopmentsinrealworldevidencerelatingtohealthtechnologyassessmentpart10
AT ramagopalansreeramv rwereadyforreimbursementaroundupofdevelopmentsinrealworldevidencerelatingtohealthtechnologyassessmentpart10